Norbert Neckel Andrej Lissat Arendt von Stackelberg Nadine Thieme Mohemed-Salim Doueiri Birgit Spors Benedicta Beck-Broichsitter Max Heiland Jan-Dirk Raguse
10.1177/1758835919878013
Ther Adv Med Oncol
2019 Oct 19;11:1758835919878013.
braf v600e-targeted therapy braf inhibitor braf mutation langerhans cell histiocytosis (lch) dental and oral rehabilitation oral lesions oral ulcers vemurafenib
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/31666812/
Case Reports
PMC6801882
31666812
Primary oral manifestation of Langerhans cell histiocytosis refractory to conventional therapy but susceptible to BRAF-specific treatment: a case report and review of the literature
2019